SCHEMBL851935

SCHEMBL851935

CCCCN(O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1701003 0.92 KDM5A (0.47)
SCHEMBL11528780 0.90 KDM5A (0.49)
SCHEMBL6253780 0.90 KDM5A (0.49)
SCHEMBL6249750 0.90 KDM5A (0.49)
SCHEMBL6253808 0.90 KDM5A (0.49)
SCHEMBL6253897 0.90 KDM5A (0.49)
SCHEMBL629319 0.83
SCHEMBL11277722 0.79
SCHEMBL6391364 0.77
SCHEMBL8815683 0.77 KDM5A (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1456311-B1 URETHANE POLYMERS THAT REDUCE THE EFFECT OF POLYLACTONE LINKAGES BASF COATINGS GMBH (DE) 2012-09-26 EP claimed
EP-1456310-B1 ASYMMETRIC DIISOCYANATE MONOMERS IN URETHANE POLYMERS AND OLIGOMERS TO REDUCE CRYSTALLINITY BASF CORP (US) 2008-02-27 EP claimed
EP-1453921-B1 CLEARCOAT COMPOSITION BASF CORP (US) 2007-05-09 EP claimed
CN-114478303-A Method for synthesizing carbidopa 浙江野风药业股份有限公司 2022-05-13 CN disclosed
EP-3313831-A1 N-SUBSTITUTED HYDROXAMIC ACIDS WITH CARBON-BASED LEAVING GROUPS AS EFFICIENT HNO DONORS AND USES THEREOF The Johns Hopkins University (US) 2018-05-02 EP disclosed
WO-2016210392-A1 N-SUBSTITUTED HYDROXAMIC ACIDS WITH CARBON-BASED LEAVING GROUPS AS EFFICIENT HNO DONORS AND USES THEREOF THE JOHNS HOPKINS UNIVERSITY (US) 2016-12-29 WO disclosed
EP-2432811-B1 CURABLE COATING COMPOSITION CONTAINING A COMPOUND HAVING A URETDIONE GROUP AND A DIFFERENT FUNCTIONAL GROUP AND CURED COATINGS BASF COATINGS GMBH (DE) 2016-03-23 EP disclosed
US-8629231-B2 Methods of making oligomers, coating compositions containing them, and coated articles BASF COATINGS GMBH (DE) 2014-01-14 US disclosed
US-8487108-B2 Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors VITAE PHARMACEUTICALS, INC. (US) 2013-07-16 US disclosed
US-8455497-B2 Inhibitors of aspartyl protease VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-06-04 US disclosed
EP-2432844-B1 OLIGOMERS HAVING URETDIONE STRUCTURE, METHODS OF MAKING THEM, COATING COMPOSITIONS CONTAINING THEM, AND CURED COATINGS THEREOF BASF COATINGS GMBH (DE) 2013-03-20 EP disclosed
US-20090275581-A1 RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. 2009-11-05 US disclosed
US-20090274650-A1 INHIBITORS OF ASPARTYL PROTEASE VERTEX PHARMACEUTICALS INCORPORATED 2009-11-05 US disclosed
US-20090264428-A1 Renin Inhibitors VITAE PHARMACEUTICALS, INC. 2009-10-22 US disclosed
US-20090186884-A1 such as N-(3-amino-2-hydroxypropyl)-3-(1-(2-(2-ethylphenoxy)phenyl)-1-hydroxy-5-;methoxypentyl)piperidine-1-carboxamide, used for the treatment of cardiovascular disorders VITAE PHARMACEUTICALS, INC. 2009-07-23 US disclosed
WO-2008124575-A1 RENIN INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-10-16 WO disclosed
WO-2008124582-A1 RENIN INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-10-16 WO disclosed
WO-2005047234-A1 METHOD FOR PRODUCING CARBAMATE GROUP-CONTAINING (METH)ACRYLIC ESTERS Röhm GmbH & Co. KG (DE) 2005-05-26 WO disclosed
US-4331438-A TREATMENT WITH A FORMALDEHYDE ACCEPTOR BASF WYANDOTTE CORPORATION (US) 1982-05-25 US disclosed
US-4160077-A Process of crosslinking unsaturated hydrocarbon polymers employing novel carbamates IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1979-07-03 US disclosed